A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients.

@article{Lorenzoni2014ABI,
  title={A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients.},
  author={Valentina Lorenzoni and Francesca Pierotti and Giuseppe Turchetti},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2014},
  volume={17 7},
  pages={A467}
}